suiseng coli/c injektionsvæske, suspension
laboratorios hipra s.a. - clostridium novyi type b alfa toxoid, clostridium perfringens type c, beta toxoid, e.coli (lt)-enterotoxin, escherichia coli, antigen 987p (f6), escherichia coli, antigen k88ab (f4ab), escherichia coli, antigen k88ac (f4ac), escherichia coli, antigen k99 (f5) - injektionsvæske, suspension
suiseng injektionsv?ske, suspension
pharmaménta aps - clostridium novyi type b alfa toxoid, clostridium perfringens type c, beta toxoid, e.coli (lt)-enterotoxin, escherichia coli, antigen 987p (f6), escherichia coli, antigen k88ab (f4ab), escherichia coli, antigen k88ac (f4ac), escherichia coli, antigen k99 (f5) - injektionsvæske, suspension
tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymfom, mantelcelle - antineoplastiske midler - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
credelio plus
elanco gmbh - lotilaner, milbemycin oxime - endektocider - hunde - for use in dogs with, or at risk from, mixed infestations/infections of ticks, fleas, gastrointestinal nematodes, heartworm and/or lungworm.
ticovac junior 1,2 mikrog./0,25 ml injektionsv?ske, suspension, fyldt injektionsspr?jte
2care4 aps - tick-borne encephalitis virus antigen (neudoerfl stamme), inaktiveret - injektionsvæske, suspension, fyldt injektionssprøjte - 1,2 mikrog./0,25 ml
locametz
novartis europharm limited - gozetotide - radionuklidbilleddannelse - diagnostiske radioaktive lægemidler - dette lægemiddel er kun til diagnostisk brug. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.
suiseng coli/c injektionsvæske, suspension
pharmaménta aps - clostridium novyi type b alfa toxoid, clostridium perfringens type c, beta toxoid, e.coli (lt)-enterotoxin, escherichia coli, antigen 987p (f6), escherichia coli, antigen k88ab (f4ab), escherichia coli, antigen k88ac (f4ac), escherichia coli, antigen k99 (f5) - injektionsvæske, suspension
bexsero
gsk vaccines s.r.l. - ydre membran vesikler fra neisseria meningitidis gruppe b (stamme nz 98/254), rekombinant neisseria meningitidis gruppe b fhbp fusion protein, rekombinant neisseria meningitidis gruppe b nada protein, rekombinant neisseria meningitidis gruppe b nhba fusion protein - meningitis, meningokok - meningokokvacciner - aktiv immunisering mod invasiv sygdom forårsaget af neisseria meningitidis serogruppe b-stammer.
covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vacciner - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
trumenba
pfizer europe ma eeig - neisseria meningitidis serogruppe b fhbp (rekombinant lipideret fhbp (faktor h bindende protein)) subfamilie a; neisseria meningitidis serogruppe b fhbp (rekombinant lipideret fhbp (faktor h bindende protein)) subfamilie b - meningitis, meningokok - bacterial vaccines, meningococcal vaccines - trumenba er indiceret til aktiv immunisering af individer 10 år og ældre for at forhindre invasiv meningokok sygdom forårsaget af neisseria meningitidis serogruppe b. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.